Bezuclastinib

Name: Bezuclastinib in Nonadvanced systemic mastocytosis: Long-term morbidity
Published: 2026-09-14T15:39:06-04:00

Nonadvanced systemic mastocytosis

Section

Long-term morbidity

1 evidence topic · 1 source

“osteosclerosis, osteopenia, osteoporosis, or osteolysis with the potential for pathologic fractures.” (opens the source at this quote in a new tab)